-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

Benzinga·10/23/2026 13:37:04
Diffusion vocale
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.